Health benefits of Mediterranean diet in nonalcoholic fatty liver disease

被引:45
|
作者
Abenavoli, Ludovico [1 ]
Di Renzo, Laura [2 ]
Boccuto, Luigi [3 ]
Alwardat, Nuha [2 ]
Gratteri, Santo [4 ]
De Lorenzo, Antonino [2 ]
机构
[1] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Viale Europa Germaneto, I-88100 Catanzaro, Italy
[2] Univ Roma Tor Vergata, Dept Biomed & Prevent, Sect Clin Nutr & Nutrigen, Rome, Italy
[3] Clemson Univ, Sch Hlth Res, Greenwood Genet Ctr, Clemson, SC USA
[4] Magna Graecia Univ Catanzaro, Dept Surg & Med Sci, Catanzaro, Italy
关键词
Food; obesity; metabolism; Nicotera; microbiota; inflammation; INFLAMMATORY GENE-EXPRESSION; RANDOMIZED CONTROLLED-TRIAL; CORONARY-HEART-DISEASE; ADEQUACY INDEX; METABOLIC SYNDROME; 25-YEAR MORTALITY; PHYSICAL-ACTIVITY; HIGH-RISK; OBESITY; POPULATION;
D O I
10.1080/17474124.2018.1503947
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Introduction: Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease worldwide. Insulin resistance and obesity-related inflammatory status, associated with genetic, dietary, and lifestyle factors, are involved in its pathogenesis. There is no consensus concerning the pharmacological treatment of NAFLD. However, the international guidelines agree to define a dietetic nutritional management to achieve weight loss, as an essential component of any therapeutic strategy.Areas covered: An overview on the beneficial effects of the Mediterranean diet in the prevention and treatment of NAFLD.Expert commentary: On the basis of its components, the literature reports the beneficial effects of the Mediterranean diet in preventing major chronic diseases, including obesity, diabetes, cardiovascular diseases, and some forms of cancers. In recent years, a growing body of evidence has supported the idea that the Mediterranean diet, associated with physical activity and cognitive behavior therapy, may be the reference nutritional profile for the prevention and the treatment of NAFLD patients.
引用
收藏
页码:873 / 881
页数:9
相关论文
共 50 条
  • [41] The Effects of Rosiglitazone, Metformin, and Diet with Exercise in Nonalcoholic Fatty Liver Disease
    Filiz Akyüz
    Kadir Demir
    Sadakat Özdil
    Nevzat Aksoy
    Şule Poturoğlu
    Duygu İbrişim
    Sabahattin Kaymakoğlu
    Fatih Beşışık
    Güngör Boztaş
    Yılmaz Çakaloğlu
    Zeynel Mungan
    Uğur Çevikbaş
    Atilla Ökten
    Digestive Diseases and Sciences, 2007, 52 : 2359 - 2367
  • [42] Nonalcoholic fatty liver disease
    Alfie, ME
    Treem, WR
    PEDIATRIC ANNALS, 2006, 35 (04): : 290 - +
  • [43] Nonalcoholic fatty liver disease
    Bayard, Max
    Holt, Jim
    Boroughs, Eileen
    AMERICAN FAMILY PHYSICIAN, 2006, 73 (11) : 1961 - 1968
  • [44] Nonalcoholic fatty liver disease
    Clark, JM
    Brancati, FL
    Diehl, AM
    GASTROENTEROLOGY, 2002, 122 (06) : 1649 - 1657
  • [46] Nonalcoholic Fatty Liver Disease
    Wang, Xiao Jing
    Malhi, Harmeet
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (09) : ITC65 - ITC80
  • [47] Nonalcoholic Fatty Liver Disease
    Sweet, Patrick H.
    Khoo, Teresa
    Nguyen, Steven
    PRIMARY CARE, 2017, 44 (04): : 599 - +
  • [48] Nonalcoholic Fatty Liver Disease
    Fitzgerald, Margaret A.
    NURSE PRACTITIONER, 2007, 32 (02): : 6 - 7
  • [49] Nonalcoholic fatty liver disease
    Elizabeth M. Brunt
    Vincent W.-S. Wong
    Valerio Nobili
    Christopher P. Day
    Silvia Sookoian
    Jacquelyn J. Maher
    Elisabetta Bugianesi
    Claude B. Sirlin
    Brent A. Neuschwander-Tetri
    Mary E. Rinella
    Nature Reviews Disease Primers, 1
  • [50] Nonalcoholic fatty liver disease
    Madan, P
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2005, 173 (07) : 734 - 735